Merck
Xilio Collaborates With Merck to Evaluate Combo of CTLA-4 and PD-1 Blockers Against Solid Tumors
2021-05-26
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
Merck Spinoff Expands Healthcare Business by Investing $240 Million in Acquiring Alydia Health
2021-03-31
Merck Acts on its Post-Keytruda Plan, Spends $1.85B to Acquire Pandion for Autoimmune Therapies
2021-02-26
Key Takeaways from the JPM Healthcare Conference: Gilead, Regeneron Lay Oncology Plans, Merck Looks Beyond Keytruda
2021-01-17
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23